Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2023

Open Access 01-12-2023 | CABG | Research

Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention

Authors: Shutong Dong, Zehao Zhao, Xin Huang, Meishi Ma, Zhiqiang Yang, Chu Fan, Hongya Han, Zhijian Wang, Dongmei Shi, Yujie Zhou

Published in: Cardiovascular Diabetology | Issue 1/2023

Login to get access

Abstract

Background

The triglyceride-glucose (TyG) index, which is a reliable substitute indicator for insulin resistance, has been considered an independent risk factor for long-term outcomes in patients with cardiovascular disease. However, it remains unknown whether the TyG index is associated with poor prognosis in acute coronary syndrome (ACS) patients with prior coronary artery bypass grafting (CABG) undergoing percutaneous coronary intervention (PCI).

Methods

A total of 1158 ACS patients with prior CABG undergoing PCI were retrospectively studied. The TyG index was calculated by ln[fasting triglyceride (mg/dL) × fasting blood glucose (mg/dL)/2]. The primary endpoint was major adverse cardiovascular and cerebrovascular events (MACCE), a composite of all-cause death, nonfatal myocardial infarction, nonfatal stroke, and unplanned repeat revascularization.

Results

During a median of 42-month follow-up, 350 patients (30.2%) experienced at least one endpoint event. Based on the optimal cut-off value of the TyG index, patients were divided into the high TyG index group and the low TyG index group. Patients in the high TyG index group had higher risks of MACCE (35.3% vs. 25.3%, p < 0.001), major adverse cardiovascular events (MACE) (31.1% vs. 23.4%, p = 0.003), nonfatal stroke (4.2% vs. 1.9%, p = 0.022) and unplanned repeat revascularization (19.4% vs. 11.3%, p < 0.001) than those in the low TyG index group. Cox regression analysis demonstrated that there was an independent association between the TyG index and MACCE regardless of whether the TyG index was a continuous or categorical variable (HR 1.42, 95% CI 1.09–1.86, p = 0.009; HR 1.53, 95% CI 1.16–2.01, p = 0.003, respectively). Restricted cubic spline curve exhibited that the relationship between the TyG index and MACCE was linear (p for non-linear = 0.595, p for overall = 0.005). By incorporating the TyG index groups into baseline risk model, the accuracy of predicting MACCE was improved [AUC: baseline risk model, 0.618 vs. baseline risk model + TyG index groups, 0.636, p for comparison = 0.042].

Conclusions

The TyG index is independently associated with MACCE, suggesting that the TyG index may serve as a valid indicator for predicting poor prognosis in ACS patients with prior CABG undergoing PCI.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021.PubMedPubMedCentralCrossRef Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021.PubMedPubMedCentralCrossRef
2.
go back to reference Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The Global Burden of Cardiovascular Diseases and Risk: a compass for Future Health. J Am Coll Cardiol. 2022;80:2361–71.PubMedCrossRef Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The Global Burden of Cardiovascular Diseases and Risk: a compass for Future Health. J Am Coll Cardiol. 2022;80:2361–71.PubMedCrossRef
3.
go back to reference Writing Committee M, Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol. 2022;79:e21–e129.CrossRef Writing Committee M, Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol. 2022;79:e21–e129.CrossRef
4.
go back to reference Chen L, Théroux P, Lespérance J, Shabani F, Thibault B, De Guise P. Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass Surgery. J Am Coll Cardiol. 1996;28:1493–9.PubMedCrossRef Chen L, Théroux P, Lespérance J, Shabani F, Thibault B, De Guise P. Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass Surgery. J Am Coll Cardiol. 1996;28:1493–9.PubMedCrossRef
5.
go back to reference Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass Surgery: results from a Department of Veterans affairs Cooperative Study. J Am Coll Cardiol. 2004;44:2149–56.PubMedCrossRef Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass Surgery: results from a Department of Veterans affairs Cooperative Study. J Am Coll Cardiol. 2004;44:2149–56.PubMedCrossRef
6.
go back to reference Morrison DA, Sethi G, Sacks J, Henderson WG, Grover F, Sedlis S, et al. Percutaneous coronary intervention versus repeat bypass Surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol. 2002;40:1951–4.PubMedCrossRef Morrison DA, Sethi G, Sacks J, Henderson WG, Grover F, Sedlis S, et al. Percutaneous coronary intervention versus repeat bypass Surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol. 2002;40:1951–4.PubMedCrossRef
7.
go back to reference Reaven GM, Banting. lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595 – 607. Reaven GM, Banting. lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595 – 607.
8.
go back to reference Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in Cardiovascular Disease development. Nat Rev Endocrinol. 2014;10:293–302.PubMedCrossRef Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in Cardiovascular Disease development. Nat Rev Endocrinol. 2014;10:293–302.PubMedCrossRef
10.
go back to reference Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13:146.PubMedPubMedCentralCrossRef Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13:146.PubMedPubMedCentralCrossRef
11.
go back to reference Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–51.PubMedCrossRef Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–51.PubMedCrossRef
12.
go back to reference Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299–304.PubMedCrossRef Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299–304.PubMedCrossRef
13.
go back to reference Wang S, Shi J, Peng Y, Fang Q, Mu Q, Gu W, et al. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 Diabetes: a real-world single-centre study. Cardiovasc Diabetol. 2021;20:82.PubMedPubMedCentralCrossRef Wang S, Shi J, Peng Y, Fang Q, Mu Q, Gu W, et al. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 Diabetes: a real-world single-centre study. Cardiovasc Diabetol. 2021;20:82.PubMedPubMedCentralCrossRef
14.
go back to reference Park HM, Lee HS, Lee YJ, Lee JH. The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 Diabetes Mellitus than the homeostatic model assessment of insulin resistance. Diabetes Res Clin Pract. 2021;180:109042.PubMedCrossRef Park HM, Lee HS, Lee YJ, Lee JH. The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 Diabetes Mellitus than the homeostatic model assessment of insulin resistance. Diabetes Res Clin Pract. 2021;180:109042.PubMedCrossRef
15.
16.
go back to reference Park B, Lee HS, Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 Diabetes among nonobese adults: a 12-year longitudinal study of the Korean genome and epidemiology study cohort. Transl Res. 2021;228:42–51.PubMedCrossRef Park B, Lee HS, Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 Diabetes among nonobese adults: a 12-year longitudinal study of the Korean genome and epidemiology study cohort. Transl Res. 2021;228:42–51.PubMedCrossRef
17.
go back to reference Khan SH, Sobia F, Niazi NK, Manzoor SM, Fazal N, Ahmad F. Metabolic clustering of risk factors: evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr. 2018;10:74.PubMedPubMedCentralCrossRef Khan SH, Sobia F, Niazi NK, Manzoor SM, Fazal N, Ahmad F. Metabolic clustering of risk factors: evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr. 2018;10:74.PubMedPubMedCentralCrossRef
18.
go back to reference Sajdeya O, Beran A, Mhanna M, Alharbi A, Burmeister C, Abuhelwa Z, et al. Triglyceride glucose index for the prediction of subclinical Atherosclerosis and arterial stiffness: a Meta-analysis of 37,780 individuals. Curr Probl Cardiol. 2022;47:101390.PubMedCrossRef Sajdeya O, Beran A, Mhanna M, Alharbi A, Burmeister C, Abuhelwa Z, et al. Triglyceride glucose index for the prediction of subclinical Atherosclerosis and arterial stiffness: a Meta-analysis of 37,780 individuals. Curr Probl Cardiol. 2022;47:101390.PubMedCrossRef
19.
go back to reference Sanchez-Inigo L, Navarro-Gonzalez D, Fernandez-Montero A, Pastrana-Delgado J, Martinez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46:189–97.PubMedCrossRef Sanchez-Inigo L, Navarro-Gonzalez D, Fernandez-Montero A, Pastrana-Delgado J, Martinez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46:189–97.PubMedCrossRef
20.
go back to reference Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with Diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19:80.PubMedPubMedCentralCrossRef Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with Diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19:80.PubMedPubMedCentralCrossRef
21.
go back to reference Zhao Q, Cheng YJ, Xu YK, Zhao ZW, Liu C, Sun TN, et al. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 Diabetes Mellitus. Cardiovasc Diabetol. 2021;20:190.PubMedPubMedCentralCrossRef Zhao Q, Cheng YJ, Xu YK, Zhao ZW, Liu C, Sun TN, et al. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 Diabetes Mellitus. Cardiovasc Diabetol. 2021;20:190.PubMedPubMedCentralCrossRef
22.
go back to reference Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation Myocardial Infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18:150.PubMedPubMedCentralCrossRef Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation Myocardial Infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18:150.PubMedPubMedCentralCrossRef
23.
go back to reference Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289–367.PubMedCrossRef Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289–367.PubMedCrossRef
24.
go back to reference Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC guidelines for the management of acute Myocardial Infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute Myocardial Infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–77.PubMedCrossRef Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC guidelines for the management of acute Myocardial Infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute Myocardial Infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–77.PubMedCrossRef
25.
go back to reference Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol. 2022;79:e21–e129.PubMedCrossRef Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol. 2022;79:e21–e129.PubMedCrossRef
26.
go back to reference Won KB, Park EJ, Han D, Lee JH, Choi SY, Chun EJ, et al. Triglyceride glucose index is an Independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol. 2020;19:34.PubMedPubMedCentralCrossRef Won KB, Park EJ, Han D, Lee JH, Choi SY, Chun EJ, et al. Triglyceride glucose index is an Independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol. 2020;19:34.PubMedPubMedCentralCrossRef
27.
go back to reference Jia X, Zhu Y, Qi Y, Zheng R, Lin L, Hu C, et al. Association between triglyceride glucose index and carotid intima-media thickness in obese and nonobese adults. J Diabetes. 2022;14:596–605.PubMedPubMedCentralCrossRef Jia X, Zhu Y, Qi Y, Zheng R, Lin L, Hu C, et al. Association between triglyceride glucose index and carotid intima-media thickness in obese and nonobese adults. J Diabetes. 2022;14:596–605.PubMedPubMedCentralCrossRef
28.
go back to reference Park GM, Cho YR, Won KB, Yang YJ, Park S, Ann SH, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery Disease in the absence of traditional risk factors. Lipids Health Dis. 2020;19:7.PubMedPubMedCentralCrossRef Park GM, Cho YR, Won KB, Yang YJ, Park S, Ann SH, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery Disease in the absence of traditional risk factors. Lipids Health Dis. 2020;19:7.PubMedPubMedCentralCrossRef
29.
go back to reference Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of Cardiovascular Diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21:124.PubMedPubMedCentralCrossRef Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of Cardiovascular Diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21:124.PubMedPubMedCentralCrossRef
30.
go back to reference Liang S, Wang C, Zhang J, Liu Z, Bai Y, Chen Z, et al. Triglyceride-glucose index and coronary artery Disease: a systematic review and meta-analysis of risk, severity, and prognosis. Cardiovasc Diabetol. 2023;22:170.PubMedPubMedCentralCrossRef Liang S, Wang C, Zhang J, Liu Z, Bai Y, Chen Z, et al. Triglyceride-glucose index and coronary artery Disease: a systematic review and meta-analysis of risk, severity, and prognosis. Cardiovasc Diabetol. 2023;22:170.PubMedPubMedCentralCrossRef
31.
go back to reference Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 Diabetes Mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19:108.PubMedPubMedCentralCrossRef Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 Diabetes Mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19:108.PubMedPubMedCentralCrossRef
32.
go back to reference Zhao Q, Zhang T-Y, Cheng Y-J, Ma Y, Xu Y-K, Yang J-Q, et al. Triglyceride-glucose index as a surrogate marker of insulin resistance for Predicting Cardiovascular outcomes in nondiabetic patients with Non-ST-Segment elevation Acute Coronary Syndrome undergoing percutaneous coronary intervention. J Atheroscler Thromb. 2021;28:1175–94.PubMedCrossRef Zhao Q, Zhang T-Y, Cheng Y-J, Ma Y, Xu Y-K, Yang J-Q, et al. Triglyceride-glucose index as a surrogate marker of insulin resistance for Predicting Cardiovascular outcomes in nondiabetic patients with Non-ST-Segment elevation Acute Coronary Syndrome undergoing percutaneous coronary intervention. J Atheroscler Thromb. 2021;28:1175–94.PubMedCrossRef
33.
go back to reference Chen L, Ding XH, Fan KJ, Gao MX, Yu WY, Liu HL, et al. Association between triglyceride-glucose index and 2-Year adverse Cardiovascular and cerebrovascular events in patients with type 2 Diabetes Mellitus who underwent off-pump coronary artery bypass grafting. Diabetes Metab Syndr Obes. 2022;15:439–50.PubMedPubMedCentralCrossRef Chen L, Ding XH, Fan KJ, Gao MX, Yu WY, Liu HL, et al. Association between triglyceride-glucose index and 2-Year adverse Cardiovascular and cerebrovascular events in patients with type 2 Diabetes Mellitus who underwent off-pump coronary artery bypass grafting. Diabetes Metab Syndr Obes. 2022;15:439–50.PubMedPubMedCentralCrossRef
34.
go back to reference Zhang H, Chong H, Li Z, Li K, Zhang B, Xue Y, et al. Triglyceride-glucose index in the prediction of major adverse cardiovascular events in patients with type 2 Diabetes Mellitus after coronary artery bypass Surgery: a retrospective cohort study. Front Endocrinol (Lausanne). 2022;13:1015747.PubMedCrossRef Zhang H, Chong H, Li Z, Li K, Zhang B, Xue Y, et al. Triglyceride-glucose index in the prediction of major adverse cardiovascular events in patients with type 2 Diabetes Mellitus after coronary artery bypass Surgery: a retrospective cohort study. Front Endocrinol (Lausanne). 2022;13:1015747.PubMedCrossRef
35.
go back to reference Welsh RC, Granger CB, Westerhout CM, Blankenship JC, Holmes DR Jr., O’Neill WW, et al. Prior coronary artery bypass graft patients with ST-segment elevation Myocardial Infarction treated with primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2010;3:343–51.PubMedCrossRef Welsh RC, Granger CB, Westerhout CM, Blankenship JC, Holmes DR Jr., O’Neill WW, et al. Prior coronary artery bypass graft patients with ST-segment elevation Myocardial Infarction treated with primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2010;3:343–51.PubMedCrossRef
36.
go back to reference Azzalini L, Ojeda S, Karatasakis A, Maeremans J, Tanabe M, La Manna A, et al. Long-term outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in patients who have undergone coronary artery bypass grafting vs those who have not. Can J Cardiol. 2018;34:310–8.PubMedCrossRef Azzalini L, Ojeda S, Karatasakis A, Maeremans J, Tanabe M, La Manna A, et al. Long-term outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in patients who have undergone coronary artery bypass grafting vs those who have not. Can J Cardiol. 2018;34:310–8.PubMedCrossRef
37.
go back to reference Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165.PubMedCrossRef Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165.PubMedCrossRef
38.
go back to reference Xiong S, Chen Q, Chen X, Hou J, Chen Y, Long Y, et al. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2022;21:145.PubMedPubMedCentralCrossRef Xiong S, Chen Q, Chen X, Hou J, Chen Y, Long Y, et al. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2022;21:145.PubMedPubMedCentralCrossRef
39.
go back to reference Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C, et al. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents. Cardiovasc Diabetol. 2021;20:137.PubMedPubMedCentralCrossRef Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C, et al. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents. Cardiovasc Diabetol. 2021;20:137.PubMedPubMedCentralCrossRef
41.
go back to reference Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of Cardiovascular Disease. Cardiovasc Diabetol. 2018;17:122.PubMedPubMedCentralCrossRef Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of Cardiovascular Disease. Cardiovasc Diabetol. 2018;17:122.PubMedPubMedCentralCrossRef
42.
go back to reference Beverly JK, Budoff MJ, Atherosclerosis. Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation. J Diabetes. 2020;12:102–4.PubMedCrossRef Beverly JK, Budoff MJ, Atherosclerosis. Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation. J Diabetes. 2020;12:102–4.PubMedCrossRef
43.
45.
go back to reference Stegenga ME, van der Crabben SN, Levi M, de Vos AF, Tanck MW, Sauerwein HP, et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes. 2006;55:1807–12.PubMedCrossRef Stegenga ME, van der Crabben SN, Levi M, de Vos AF, Tanck MW, Sauerwein HP, et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes. 2006;55:1807–12.PubMedCrossRef
46.
go back to reference Undas A, Wiek I, Stêpien E, Zmudka K, Tracz W. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care. 2008;31:1590–5.PubMedPubMedCentralCrossRef Undas A, Wiek I, Stêpien E, Zmudka K, Tracz W. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care. 2008;31:1590–5.PubMedPubMedCentralCrossRef
47.
go back to reference Trifunovic D, Stankovic S, Sobic-Saranovic D, Marinkovic J, Petrovic M, Orlic D, et al. Acute insulin resistance in ST-segment elevation Myocardial Infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function. Cardiovasc Diabetol. 2014;13:73.PubMedPubMedCentralCrossRef Trifunovic D, Stankovic S, Sobic-Saranovic D, Marinkovic J, Petrovic M, Orlic D, et al. Acute insulin resistance in ST-segment elevation Myocardial Infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function. Cardiovasc Diabetol. 2014;13:73.PubMedPubMedCentralCrossRef
Metadata
Title
Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention
Authors
Shutong Dong
Zehao Zhao
Xin Huang
Meishi Ma
Zhiqiang Yang
Chu Fan
Hongya Han
Zhijian Wang
Dongmei Shi
Yujie Zhou
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2023
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-02029-6

Other articles of this Issue 1/2023

Cardiovascular Diabetology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine